US Navy Deploys Supercarrier USS George Washington in the IndoPacific Strategic and Market Implications Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday SP 500 Edges Higher as Consumer Staples and Discretionary Lead Tech Slips Best HighYield Savings Interest Rates Today May 22 2026 Up to 410 APY Return China Urges APEC Unity as Trade Minister Steps In for Absent Commerce Chief Could SpaceXs MegaIPO Signal a Market Peak Analysts Weigh In KZR Q1 2026 Earnings EPS Miss Highlights Cash Burn as Company Advances Pipeline PTC Q1 2026 Earnings Strong EPS Beat Fuels Cautious Optimism Amid Slight Stock Dip CUZ Q1 2026 Earnings EPS Beats Estimates by 155 Shares Edge Higher Talphera Inc TLPH Q1 2026 Earnings Narrower Loss Surprises Analysts as Company Advances Pipeline Lineage Cell Therapeutics Inc LCTX Q1 2026 Earnings Miss on EPS as ClinicalStage Biotech Continues Development PPBT Q1 2025 Earnings Narrowing Losses and Pipeline Progress Drive Optimism Rezolve AI Warrants RZLVW Stabilizes at 093 as Price Action Consolidates Between Key Levels Vera Bradley VRA Slides 204 as Shares Test Support Near 319 Western Alliance Bancorporation Holds Steady Near 7859 as Consolidation Continues Roadzen Warrants RDZNW Surge 23 Momentum Builds Above Key Support Precision Optics POCI Moves Higher Amid Consolidation Support and Resistance Define Trading Range Jobless Claims Remain at Historically Low Levels Signaling Labor Market Strength Ingles Markets Q1 2026 Earnings EPS of 128 Supports Stock Gain Amid Limited Disclosure ARKO Corp Holds Near Support Amid Modest Uptick Winnebago Q1 2026 Earnings Operational Discipline Drives EPS Surprise Amid Subdued Demand Cemtrex Inc CETX Q3 2024 Earnings EPS Misses Estimates as Loss Widens Allot Ltd Q1 2026 Earnings EPS Beat Drives Stock Higher LGND Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Operational Strength Data Storage Corporation DTST Q1 2026 Earnings Earnings Surprise Driven by NarrowerThanExpected Loss OIS Q1 2026 Earnings EPS Slightly Exceeds Estimates Amid Mixed Market Conditions C4 Therapeutics CCCC Q1 2026 Earnings Narrowing Losses Drive Surprise Beat Despite Zero Revenue